Harvard Bioscience, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 10, 2026, reporting financial results for both the three and nine months ended on that date.
Acme United Corporation filed its quarterly report on Form 10-Q for the period ended September 30, 2026, disclosing third-quarter net sales of $58,013 thousand and nine-month net income of $9,469 thousand.
Director Brian Barker filed a Form 4 with the SEC on November 10, 2026, disclosing the sale of Acme United Corporation common stock on November 9, 2026.
Stran & Company, Inc. filed a Form 8-K on November 10, 2026, announcing its financial results for the three and nine months ended September 30, 2026, and scheduling a conference call for November 11, 2026.
Stran & Company, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the period ended September 30, 2026, disclosing a return to profitability for the nine-month period and growth in total assets.
Precipio, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting condensed consolidated financial results for the three and nine months ended on that date.
Precipio, Inc. filed a Form 8-K on November 10, 2026, announcing the release of its financial results for the second quarter ended September 30, 2026.
Lake Shore Bancorp, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the three and nine months ended September 30, 2026.
Marathon Bancorp, Inc. filed a Form 10-Q with the SEC on November 10, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026.
Zion Oil & Gas, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, reporting continued operating losses and significant equity-raising activity through its Direct Stock Purchase Plan.